Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 0.00 shares.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 696.00 shares.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 134.00 shares.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 830.00 shares, a 71.27% decline from fiscal 2017.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 2.89K shares, a 64.32% decline from fiscal 2016.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 8.10K shares, a 96.28% decline from fiscal 2015.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 217.57K shares, a 53.17% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-04-10 | 830.00 shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | 830.00 shares 10-K · filed 2019-03-04 |
| 2018-09-30 | 696.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 2.32K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 134.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 1.62K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-08 | 1.49K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 1.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 2.89K shares 10-K · filed 2018-03-13 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | 1.40K shares derived: sum of 4 quarters · filed 2017-10-25 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 1.40K shares derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | 1.40K shares 10-Q · filed 2017-05-09 | 1.40K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 8.10K shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 62.77K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 194.00K shares derived: sum of 4 quarters · filed 2016-08-02 |
| 2016-03-31 | 8.10K shares 10-Q · filed 2016-05-09 | 198.10K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 54.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 217.57K shares 10-K · filed 2016-03-08 |
| 2015-09-30 | 131.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 304.82K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 4.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | |
| 2015-03-31 | 27.56K shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 141.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20 | 142.04K shares 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |